NM_000548.5:c.4352G>A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000548.5(TSC2):c.4352G>A(p.Arg1451His) variant causes a missense change. The variant allele was found at a frequency of 0.0000193 in 1,607,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152218Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000376 AC: 9AN: 239510Hom.: 0 AF XY: 0.0000228 AC XY: 3AN XY: 131514
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1454886Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 724062
GnomAD4 genome AF: 0.000105 AC: 16AN: 152218Hom.: 0 Cov.: 34 AF XY: 0.000121 AC XY: 9AN XY: 74356
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Uncertain:1Benign:3
- -
This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -
- -
- -
TSC2-related disorder Uncertain:1
The TSC2 c.4352G>A variant is predicted to result in the amino acid substitution p.Arg1451His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.034% of alleles in individuals of African descent in gnomAD. This variant has conflicting interpretations in ClinVar ranging from variant of uncertain significance to benign (https://www.ncbi.nlm.nih.gov/clinvar/variation/238046/.) Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at